Interim Results of MATCH Study Demonstrate Improved Decision Making and Clinical Outcomes When Using Mind.Px™ to Determine Biologic Drug Class for Psoriasis Patients read more 10/20/22
MINDERA™ ANNOUNCES PUBLICATION OF AN ECONOMIC EVALUATION OF PRECISION MEDICINE TESTING FOR THE TREATMENT OF PSORIASIS read more 07/19/21
PhaseBio Announces European Licensing Agreement with Alfasigma S.p.A for Commercialization of Bentracimab read more 06/17/21
Clearside Biomedical Announces Positive Safety Results from Cohort 1 of OASIS Phase 1/2a Clinical Trial of CLS-AX (axitinib injectable suspension) for the Treatment of Wet AMD read more 06/15/21
ALSS Secures $7M Series B Funding To Commercialize Novel Vaccine Delivery System For Poultry Industry read more 05/12/21
